Sophia Genetics SA reports results for the quarter ended in March - Earnings Summary

Sophia Genetics SA

09/05/2023 14:32

* Sophia Genetics SA  SOPH.OQ  reported a quarterly adjusted
loss
of 31 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 32 cents per share.
    * Revenue rose 28.6% to $13.97 million from a year ago;
analysts
expected $13.89 million. 
    * Sophia Genetics SA's reported EPS for the quarter was a
loss
of 31 cents​.
    * The mean earnings estimate of analysts had risen by
about 15.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Sophia Genetics SA shares had fallen by 4.2% this
quarter and
gained 131.1% so far this year.
    * The company reported a quarterly loss of $19.7 million.
    * Wall Street's median 12-month price target for Sophia
Genetics
SA is $8.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.32          -0.31          Beat
 Dec. 31 2022      -0.36          -0.22          Beat
 Sep. 30 2022      -0.38          -0.30          Beat
 Jun. 30 2022      -0.39          -0.31          Beat